Genetic Predictors of Lithium Response
Lithium remains a first-line pharmacological treatment of bipolar disorder (BD). However, treatment response is heterogeneous, with several lines of evidence implicating genetic factors. Unfortunately, neither hypothesis-driven approaches nor initial genome-wide association studies (GWAS) were succe...
Saved in:
Main Author: | U. Heilbronner |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2019-12-01
|
Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
Subjects: | |
Online Access: | https://www.bekhterevreview.com/jour/article/view/295 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The International Consortium of Lithium Genetics (ConLiGen): Achievements and Collaborations
by: U. Heilbronner
Published: (2019-12-01) -
Evaluation of novel candidate variations and their interactions related to bipolar disorders: Analysis of GWAS data
by: Acikel C, et al.
Published: (2016-11-01) -
Human Blood-Derived lncRNAs in Autism Spectrum Disorder
by: Carmela Serpe, et al.
Published: (2025-06-01) -
The role of long, non-coding RNA in the biology of tumors
by: O. A. Beylerli, et al.
Published: (2020-04-01) -
3plex Web: An interactive platform for RNA:DNA triplex prediction and analysis
by: Marco Masera, et al.
Published: (2025-01-01)